Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase
- 1 February 1995
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 34 (2) , 121-137
- https://doi.org/10.1002/ddr.430340205
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- The 3Rs of life: Ras, Raf and growth regulationTrends in Genetics, 1994
- Endoproteolysis of non-CAAX-containing isoprenylated peptidesFEBS Letters, 1993
- Identification of a Ten-Amino Acid Proline-Rich SH3 Binding SiteScience, 1993
- Substrate specificity of the isoprenylated protein endoproteaseBiochemistry, 1992
- SH2 and SH3 domains: From structure to functionCell, 1992
- Characterization of an acyltransferase acting on p21N-ras protein in a cell-free systemBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Characterization of specific binding sites for [3H]-staurosporine on various protein kinasesBiochemical and Biophysical Research Communications, 1990
- Independent Molecular Pathways in Initiation and Loss of Hormone Responsiveness of Breast CarcinomasScience, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986